Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

Share Price is delayed by 15 minutes
Get Live Data
290.00    -9.00 (-3.01%)
Bid:
290.00
Ask:
294.00
Spread: 4.00 (1.379%)
Market Cap: £258.76m
NXR Live PriceLast checked at - London Stock Exchange

Intraday Norcros Share Chart

Trading Update

11 Oct 2018 07:00

RNS Number : 6598D
Norcros PLC
11 October 2018
 

 

11 October 2018

 

("Norcros", the "Group" or the "Company")

 

Trading Update

 

Norcros, a market leading supplier of high quality and innovative bathroom and kitchen products will announce its interim results for the half year ended 30 September 2018 on 15 November 2018. In advance of this, the Group is providing the following trading update.

 

 

Trading

 

Group underlying operating profit1 for the first half is expected to be in line with the Board's expectations reflecting a robust performance and continuing to demonstrate the financial resilience of the Group.

 

Group revenue for the first half is expected to be approximately £162.5m (2017: £145.0m), 12.1% higher than the prior year on a reported basis, 13.2% higher on a constant currency basis, and level on a like for like2 constant currency basis. This performance reflected strong organic revenue growth of 4.4% in the Group, excluding the significantly lower revenue from Johnson Tiles which was anticipated and largely due to the Kingfisher unified programme as previously reported.

 

 

Half year to 30 September 2018 Revenue

 

Reported

Constant currency

Constant currency LFL2

 

 

 

 

UK

+16.4%

+16.4%

- 4.2%

 

 

 

 

South Africa

+3.9%

+7.1%

+7.1%

 

 

 

 

Group

 

+12.1%

 

+13.2%

 

- 0.3%

 

 

Underlying operating profit excludes IAS 19R administrative expenses, acquisition related costs and exceptional operating items

2 LFL / like for like excludes Merlyn revenues (acquired 23 November 2017)

 

 

UK revenue for the first half was 16.4% higher than the prior year, reflecting in part the contribution from Merlyn, which continued to perform strongly in the period. On a like for like basis2 , and excluding Johnson Tiles, UK revenue was 2.5% higher, reflecting a very resilient performance as trading conditions, particularly in the UK retail sector and a number of export markets, were challenging. The restructuring of the Johnson Tiles business, as announced in April, is proceeding to plan with the business back into profit in the first half.

 

Revenue grew in our South African business by 7.1% compared to the prior year, on a constant currency basis and by 3.9% on a reported basis reflecting the weaker South African Rand. 

 

  

Financial position

 

Closing half year net debt is expected to be around £54m (2017: £20.8m), in line with expectations following the acquisition of Merlyn in the second half of last year.

 

Outlook

 

The robust performance in the first half against the backdrop of a challenging trading environment continues to demonstrate the strength of our market positions, our leading brands and the financial resilience of our diversified business model. The Board remains confident that these attributes will continue to drive market outperformance and will enable the Group to make further progress in line with its expectations for the year to 31 March 2019.

 

 

ENQUIRIES:

 

Norcros plc

Tel: 01625 547 700

Nick Kelsall, Group Chief Executive

 

Shaun Smith, Group Finance Director

 

 

 

Hudson Sandler

Tel: 0207 796 4133

Nick Lyon

Nelly Akpaka

 

Anneka Jirh

 

 

 

 

Notes to Editors

· Norcros is a leading supplier of high quality and innovative bathroom and kitchen products with operations primarily in the UK and South Africa.

 

· Based in the UK, Norcros operates under seven brands:

· Triton - Market leader in the manufacture and marketing of showers in the UK

· Merlyn - the UK and Ireland's No. 1 supplier of shower enclosures and trays to the residential, commercial and hospitality sectors

· Vado - A leading manufacturer and supplier of taps, mixer showers, bathroom accessories and valves

· Croydex - A market-leading, innovative designer, manufacturer and distributor of high-quality bathroom furnishings and accessories

· Abode - A leading niche designer and distributor of high-quality kitchen taps, bathroom taps and kitchen sinks

· Johnson Tiles - A leading manufacturer and supplier of ceramic tiles in the UK

· Norcros Adhesives - Manufacturer of tile & stone adhesives, grouts and related products

 

· Based in South Africa, Norcros operates under three brands:

· Tile Africa - Chain of retail stores focused on ceramic and porcelain tiles, and associated products such as sanitary ware, showers and adhesives

· Johnson Tiles South Africa - Manufacturer of ceramic and porcelain tiles

· TAL - The leading manufacturer of ceramic and building adhesives

 

· Norcros is headquartered in Wilmslow, Cheshire and employs around 2,100 people. The Company is listed on the London Stock Exchange. For further information please visit the Company website: http://www.norcros.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTQBLFFVBFZFBL
Date   Source Headline
15th Dec 20229:40 amRNSBoard Changes
9th Nov 20227:00 amRNSInterim Results
1st Nov 202212:07 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
30th Sep 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Sep 20227:00 amRNSVoting Rights and Share Capital Update
13th Sep 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20229:39 amRNSVoting Rights and Share Capital Update
26th Jul 202212:30 pmRNSHolding(s) in Company
25th Jul 20222:23 pmRNSDirectors' Dealings
19th Jul 20222:05 pmRNSResults of AGM
19th Jul 20221:57 pmRNSDirector Dealings
19th Jul 20227:00 amRNSAGM Trading Statement
15th Jul 20225:08 pmRNSVoting Rights and Share Capital Update
30th Jun 20229:08 amRNSVoting Rights and Share Capital Update
21st Jun 20225:21 pmRNSDirector Declaration
16th Jun 202211:16 amRNSNotice of AGM Annual Report Announcement
14th Jun 20222:25 pmRNSHoldings in Company
9th Jun 20227:00 amRNSFinal Results
31st May 20221:01 pmRNSCompletion of Acquisition of Grant Westfield
31st May 20227:00 amRNSVoting Rights and Share Capital Update
30th May 202211:07 amRNSResult of General Meeting
16th May 20222:19 pmRNSHolding(s) in Company
12th May 202212:08 pmRNSPublication and Posting of Circular
12th May 20227:00 amRNSResults of Placing
11th May 20224:41 pmRNSProposed Placing
11th May 20224:41 pmRNSProposed Acquisition of Grant Westfield
29th Apr 20224:53 pmRNSTotal Voting Rights
26th Apr 20225:16 pmRNSHolding(s) in Company
25th Apr 20225:50 pmRNSHolding(s) in Company
21st Apr 20223:01 pmRNSHolding(s) in Company
14th Apr 20227:00 amRNSTrading Update
8th Apr 20223:40 pmRNSHolding(s) in Company
31st Mar 20225:16 pmRNSTotal Voting Rights and Share Capital Update
18th Mar 202211:15 amRNSHolding(s) in Company
24th Jan 20227:00 amRNSSenior Management Appointment
20th Jan 20221:37 pmRNSRemuneration Resolution Vote - AGM 2021
8th Dec 20217:00 amRNSDirectorate Changes
11th Nov 20217:00 amRNSInterim Results
1st Nov 20219:16 amRNSTotal Voting Rights
14th Oct 20217:00 amRNSTrading Update
30th Sep 20217:05 amRNSTotal Voting Rights
30th Sep 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Sep 20213:37 pmRNSHolding(s) in Company
31st Aug 202110:46 amRNSTotal Voting Rights
27th Aug 20214:59 pmRNSHolding(s) in Company
2nd Aug 20217:00 amRNSTotal Voting Rights
28th Jul 20217:00 amRNSSenior Management Appointments
27th Jul 20215:35 pmRNSDirectors' Dealings
21st Jul 20213:03 pmRNSDirector Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.